On March 1, 2020, Nihon Parkerizing Co., Ltd. , together with Kobayashi Pharmaceutical Co., Ltd. and the Japan Aerospace Exploration Agency (JAXA) launched a joint research and development project (hereinafter, the “joint research”) to develop antibacterial treatment technology for use within spacecraft with the objective of applying this technology to manned space activity, a field that is anticipated to expand in future. The joint research aims to facilitate a spacecraft onboard environment that is suitable for more hygienic long-term stays.